Reviewing Coeptis Therapeutics (NASDAQ:ZSQR) and SoundHound AI (NASDAQ:SOUN)

Coeptis Therapeutics (NASDAQ:ZSQR) and SoundHound AI (NASDAQ:SOUN) are both technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Coeptis Therapeutics and SoundHound AI, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coeptis Therapeutics	1	0	0	0	1.00
SoundHound AI	1	2	3	1	2.57

SoundHound AI has a consensus target price of $12.75, suggesting a potential upside of 118.70%. Given SoundHound AI’s stronger consensus rating and higher possible upside, analysts plainly believe SoundHound AI is more favorable than Coeptis Therapeutics.

Valuation & Earnings

This table compares Coeptis Therapeutics and SoundHound AI”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coeptis Therapeutics	$1.36 million	176.93	-$11.92 million	($1.63)	-2.79
SoundHound AI	$168.92 million	15.33	-$14.01 million	($0.38)	-15.34

Coeptis Therapeutics has higher earnings, but lower revenue than SoundHound AI. SoundHound AI is trading at a lower price-to-earnings ratio than Coeptis Therapeutics, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Coeptis Therapeutics has a beta of -0.25, indicating that its share price is 125% less volatile than the S&P 500. Comparatively, SoundHound AI has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500.

Insider and Institutional Ownership

13.9% of Coeptis Therapeutics shares are held by institutional investors. Comparatively, 19.3% of SoundHound AI shares are held by institutional investors. 24.2% of Coeptis Therapeutics shares are held by insiders. Comparatively, 8.8% of SoundHound AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Coeptis Therapeutics and SoundHound AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Coeptis Therapeutics	-773.72%	-49.45%	-46.88%
SoundHound AI	-67.45%	-30.22%	-20.28%

Summary

SoundHound AI beats Coeptis Therapeutics on 11 of the 15 factors compared between the two stocks.

About Coeptis Therapeutics

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

About SoundHound AI

SoundHound AI, Inc. develops independent voice artificial intelligence (AI) solutions that enables businesses across automotive, TV, and IoT, and to customer service industries to deliver high-quality conversational experiences to their customers. Its products include Houndify platform that offers a suite of Houndify tools to help brands build conversational voice assistants, such as Application Programming Interfaces (API) for text and voice queries, support for custom commands, extensive library of content domains, inclusive software development kit platforms, collaboration capabilities, diagnostic tools, and built-in analytics; SoundHound Chat AI that integrates with knowledge domains, pulling real-time data like weather, sports, stocks, flight status, and restaurants; and SoundHound Smart Answering is built to offer customer establishments custom AI-powered voice assistant. The company's products also include CaiNET software that uses machine learning to enhance how domains work together to handle queries; CaiLAN software that arbitrates responses so users get answers from the right domain; Dynamic Interaction a real-time, multimodal customer service interface; Smart Ordering which offers an easy-to-understand voice assistant for restaurants; Employee Assist; automatic speech recognition; natural language understanding; wake words; custom domains; text-to-speech; and embedded voice solutions. The company was founded in 2005 and is headquartered in Santa Clara, California.